Axiora Medical
Reconstruction within the craniomaxillofacial (CMF) complex demands unprecedented mechanical integrity, micro-tolerance dimensions, and long-term bio-compatibility. The human skull, face, and jaw constitute an intricate assembly of structural units subject to continuous functional stress during mastication, speech, and respiratory kinetics. Axiora Medical Technology (China) Co., Ltd. sits at the forefront of this surgical discipline. We engineer, manufacture, and export surgical-grade osteosynthesis implants. Specifically, our titanium maxillofacial plating systems are optimized for rigid internal fixation, trauma recovery, orthognathic correction, and pediatric craniofacial reconstruction.
Our deep-level OEM and ODM services utilize state-of-the-art CNC Swiss machining centers, high-tolerance milling installations, and automated electrochemical anodization setups to output medical-grade titanium (Ti-6Al-4V ELI / Ti Grade 4) and premium polymeric materials like PEEK. Supported by 86 dedicated R&D engineers and 48 quality control specialists, we implement rigorous incoming-material validation and 100% finished-product dimensional audits. Through these comprehensive methods, we ensure that every plate, mesh, and locking screw we manufacture is aligned with international clinical standards.
| Item | Details |
|---|---|
| Company Name | Axiora Medical Technology (China) Co., Ltd. |
| Brand | Axiora |
| Website | www.axioraortho.com |
| Established | 2017 |
| Factory Area | 18,600 m² |
| Annual Export Revenue | USD 26 Million |
| Export Experience | 8 Years |
| Quality Inspection | 100% Finished Product Inspection & Incoming Material Inspection |
| Product Inspection Methods | Coordinate Measuring Machine (CMM), Tensile Testing, Hardness Testing, Surface Roughness Inspection, Salt Spray Testing |
| Quality Control Staff | 48 Quality Control Professionals |
| Business Type | Manufacturer & Exporter (OEM/ODM/OBM) |
| Main Markets | Europe, North America, Middle East, Southeast Asia, South America, Africa |
| Supply Chain Partners | 1,120 Globally Networked Logistics and Raw Material Providers |
| R&D Capability | Independent Product Design, Finite Element Analysis (FEA), Reverse Engineering, OEM & ODM Prototyping |
| Customization Options | Laser Logo Marking, Private Labeling, Sterile/Non-Sterile Packaging, Custom Plate Geometry, Titanium Color Anodizing |
| New Products Released Last Year | 126 New SKUs & Product Iterations |
Modern maxillofacial surgery demands plating systems that balance structural support with physiological comfort. Because facial bones are thinner and subject to multi-directional forces, conventional orthopedic trauma plates are inadequate. Instead, CMF fixation requires specialized micro, mini, and mid-sized plating profiles (typically ranging from 1.0mm, 1.3mm, 1.5mm, 2.0mm to 2.4mm screw diameter designs) to minimize hardware palpability while ensuring skeletal stability.
Axiora uses ultra-purified medical titanium, primarily ISO 5832-2 Class 4 Pure Titanium (for high-bend contourability) and ISO 5832-3 Ti-6Al-4V ELI (for areas requiring superior fatigue strength and pull-out resistance). Through electro-anodization, our implants receive a controlled oxide layer. This layer color-codes the systems by thickness for easier intraoperative identification while enhancing passivation to prevent galvanic corrosion and ensure optimal osseointegration.
Development of malleable, low-profile plating patterns for orbital floor repair, midface trauma, and orthognathic advancement, minimizing anatomical prominence.
Implementation of lockable screw-to-plate configurations to prevent plate-to-bone compression, preserving periosteal vascularization and boosting construct stability.
Integrating 3D CAD/CAM models from patient CT data to mill customized PEEK or 3D-print (selective laser melting) titanium meshes for reconstruction of major defects.
Axiora runs a digital-first, vertically integrated manufacturing plant spanning 18,600 m². We have automated our production floor with Swiss CNC longitudinal cutting lathes, precise multi-axis grinding equipment, and class-10,000 cleanrooms for sterile packaging. This digital integration allows us to trace each raw batch of titanium back to its origin certificate, maintaining a transparent auditing trail for medical authorities like the FDA, NMPA, and European notified bodies.
Below, we detail our step-by-step production cycle. This systematic approach ensures that every implant is manufactured with high consistency, dimensional accuracy, and clean surfaces, maintaining our standard of zero-defect medical-grade shipments.
Navigating medical device registrations globally is complex. Regulatory frameworks like the EU MDR 2017/745 and FDA 510(k) place high demands on technical documentation and clinical evaluation reports. Axiora helps distributors and OEM partners streamline registration by providing comprehensive regulatory support files.
We provide complete documentation, including biological evaluation reports (ISO 10993 series), steam sterilization validations (ISO 17665), packaging integrity tests, and cleanroom environmental records. These resources are designed to expedite local regulatory clearance for import markets worldwide.
Our on-site engineering team handles drawing interpretation and manufacturing adjustments, ensuring your customized orders transition smoothly from prototype to clinical validation.
In today's medical supply chain, volatility in raw materials and logistics is a major risk. Axiora helps partners build resilient procurement programs. By holding large reserves of certified medical titanium rod stock and maintaining partnerships with 1,120 active supply partners, we protect our clients from sudden price spikes and material shortages.
We offer flexible pricing options, raw material forecasting models, and support for high-volume public tenders. Additionally, we run a reliable logistics network to manage air cargo, customs clearance, and cold-chain shipments, helping you avoid port delays.